An appeals court has upheld a $22.2 million jury verdict in a long-standing patent spat between Integer Holdings (NYSE:ITGR), formerly known as Greatbatch, and AVX, now part of Kyocera. In a ruling released today, a three-judge panel of the U.S. Court of Appeals agreed with a lower court decision that AVX intentionally infringed certain Integer patents with its Ingenio […]
Kyocera
10 orthopedic products from AAOS 2019 you need to know
The American Academy of Orthopaedic Surgeons (AAOS) annual meeting in Las Vegas is abuzz about robotics, according to industry analysts from SVB Leerink. While the SVB Leerink analysts termed Stryker’s (NYSE:SYK) Mako platform “best-in-class,” it’s an expanding category. Other major orthopedics companies are using this week’s AAOS meeting to introduce new offerings or tout updates to existing […]
FDA clears Kyocera Medical’s Initia hip implant
Implantable medical systems maker Kyocera Medical said today it won FDA 510(k) clearance for its Initia total hip implant system. The Japanese company’s Initia total hip system includes Bioceram Azul zirconia-toughened alumina ceramic femoral heads, or can be requested with cobalt chrome femoral heads. The system includes a total 16 tapered-wedge stem sizes, with 12 […]
Amedica, Kyocera ink deal for silicon nitride medical devices
Amedica Corp. entered into an agreement with Kyocera Industrial Ceramics Corp. to manufacture Amedica’s silicon nitride biomaterial at Kyocera’s Vancouver, Wash., facility.
The FDA-cleared silicon nitride has the potential to promote bone growth defend against infection. Devices made from silicon nitride are semi-radiolucent with clearly visible boundaries, enabling an exact view of intra-operative placement and postoperative fusion assessment via common imaging modalities, according to a press release.
